Journal article · 2026 · Open access

Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective

Twinsi Ashishbhai Prajapati, Krupa Kalpeshbhai Akbari, Shrutiben Piyushbhai Patel, Shreyaben Piyushbhai Patel, Amar M. Raval, DR. AASTHA UKANI

Pharmacology and Toxicology Research, 2, 29–40 · Published 7 September 2026 · DOI 10.68163/ptr.2026.69

Open PDFView at the publisherCite this paper

In brief

“Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective” is a 2026 journal article by Twinsi Ashishbhai Prajapati and 5 co-authors, published in Pharmacology and Toxicology Research. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Pharmacology and Toxicology Research.

Citations
0
References
22
Authors
6

Abstract

Organ-on-a-chip (OOC) technology has emerged as a transformative microphysiological platform that addresses the limitations of conventional two-dimensional cell cultures and animal models in recapitulating human physiology. By integrating microfluidics, tissue engineering, biomaterials and living human cells within controlled microenvironments, OOC systems can recapitulate key structural, mechanical and biochemical features of native tissues and organs. Recent advances have enabled the development of diverse organ-specific and multi-organ platforms capable of modeling complex physiological and pathological processes, including tissue-tissue interactions, barrier function, immune responses and drug-induced toxicity. Furthermore, the integration of organ-on-a-chip technology with stem-cell-derived organoids has enhanced biological fidelity by combining self-organizing tissue architecture with precise environmental control. These platforms have demonstrated significant potential for disease modeling, predictive toxicology, efficacy screening, pharmacokinetic studies and personalized medicine through the use of patient-derived cells and disease-specific models. The emerging integration of artificial intelligence and advanced biosensing technologies further expands their capacity for automated analysis, high-content data interpretation and precision pharmacology. Despite substantial progress, challenges related to standardization, reproducibility, scalability, regulatory validation and commercialization continue to limit widespread adoption. This review examines the engineering foundations, biological applications and translational significance of organ-on-a-chip systems, with particular emphasis on their roles in drug discovery and personalized medicine. Additionally, current limitations, regulatory considerations and future perspectives are discussed to evaluate the potential of these platforms as next-generation tools for human-relevant biomedical research and precision therapeutics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Prajapati, T. A., Akbari, K. K., Patel, S. P., Patel, S. P., Raval, A. M., & UKANI, D. A. (2026). Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective. Pharmacology and Toxicology Research, 2, 29–40. https://doi.org/10.68163/ptr.2026.69

MLA 9

Prajapati, Twinsi Ashishbhai, et al. “Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective.” Pharmacology and Toxicology Research, vol. 2, 2026, pp. 29–40. https://doi.org/10.68163/ptr.2026.69.

Chicago

Prajapati, Twinsi Ashishbhai, Krupa Kalpeshbhai Akbari, Shrutiben Piyushbhai Patel, Shreyaben Piyushbhai Patel, Amar M. Raval, and DR. AASTHA UKANI. 2026. “Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective.” Pharmacology and Toxicology Research 2: 29–40. https://doi.org/10.68163/ptr.2026.69.

Harvard

Prajapati, T. A. et al. (2026) ‘Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective’, Pharmacology and Toxicology Research, 2, pp. 29–40. doi:10.68163/ptr.2026.69.

IEEE

T. A. Prajapati, K. K. Akbari, S. P. Patel, S. P. Patel, A. M. Raval, and D. A. UKANI, “Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective,” Pharmacology and Toxicology Research, vol. 2, pp. 29–40, 2026, doi: 10.68163/ptr.2026.69.

BibTeX

@article{prajapati2026organ,
  title     = {{Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective}},
  author    = {Prajapati, Twinsi Ashishbhai and Akbari, Krupa Kalpeshbhai and Patel, Shrutiben Piyushbhai and Patel, Shreyaben Piyushbhai and Raval, Amar M. and UKANI, DR. AASTHA},
  journal   = {Pharmacology and Toxicology Research},
  year      = {2026},
  volume    = {2},
  pages     = {29--40},
  doi       = {10.68163/ptr.2026.69},
  url       = {https://doi.org/10.68163/ptr.2026.69}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research

  • organ-on-a-chip
  • drug discovery
  • personalized medicine
  • microphysiological systems
  • organoids
  • disease modeling
  • predictive toxicology
  • patient-derived cells

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Prajapati, T. A., Akbari, K. K., Patel, S. P., Patel, S. P., Raval, A. M., & UKANI, D. A. (2026). Organ-on-a-Chip Platforms for Drug Discovery and Personalized Medicine: Current Advances, Applications and Future Perspective. Pharmacology and Toxicology Research, 2, 29–40. https://doi.org/10.68163/ptr.2026.69

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmacology and Toxicology Research: sign in and open the PDF from this page.

Who wrote this paper?

Twinsi Ashishbhai Prajapati, Krupa Kalpeshbhai Akbari, Shrutiben Piyushbhai Patel, Shreyaben Piyushbhai Patel, Amar M. Raval, DR. AASTHA UKANI.

What is the DOI of this paper?

10.68163/ptr.2026.69, permanently at https://doi.org/10.68163/ptr.2026.69. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.